The expectation is that in the general population, the risk of cardiovascular abnormalities is about one in 100 babies, spokeswoman Gaile renege, GlaxoSmithKline tells WebMD.We should consider stopping [Paxil] or perhaps switch to another antidepressant, unless the mother feels that the benefits justify the continuation of treatment, says renege.
Heart defects reported in these studies were holes in the walls of the chambers of the heart .
In the other study, the risk of heart defects in babies whose mothers took Paxil during the first three months of pregnancy was 1.5 percent, compared to 1 percent in infants whose mothers took antidepressants while in other the first three months of pregnancy. Weight Risks and benefits
GlaxoSmithKline, a WebMD sponsor, send a letter to doctors the latest information. Birth defects linked to more heart
This reflects a stronger warning about use during early pregnancy. D drugs have shown the risk to the fetus in studies of pregnant women. However, in this category, the benefits of treatment outweigh the risks.
She says that studies show a risk of birth defects related to the heart is one of 50 children born to women who used Paxil in early pregnancy. Cause not Erase
The FDA and GlaxoSmithKline drugs have strengthened warnings on the use of the drug for the first time.
Press releases from the FDA notes that the benefits of treatment outweigh the potential risks to the fetus. ‘ In labeling, I think there are some important tips for prescribers and patients to note renege said.
In general, the FDA said, these types of defects off the severity of those that are minor and may resolve without treatment to those that cause serious symptoms and may need to be surgically repaired. The results of the study ‘
The studies did not assign anyone to take Paxil and do not necessarily prove that Paxil caused these birth defects.
The first of these studies have prompted a warning from the FDA and a drug-to-date and a warning label medicine labelFDA updated by GlaxoSmithKline, which makes Paxil, in September.
The labeling now suggests that patients who become pregnant while taking [Paxil] should certainly be aware of potential risks to the fetus, he said.
For women who intend to become pregnant or are in their first trimester of pregnancy, and other treatment options should be considered before starting Paxil. So what are the recommendations that GSK and support from the FDA to help put this information in a useful context for physicians and women to make well-informed treatment decisions, he said. Creator Comment
The warning is based on early results of two studies. Studies have shown a higher rate of heart-related in children born to women who took Paxil during pregnancy compared to infants of women in the general population or women who took other antidepressants.
In one study, the risk of heart defects in babies whose mothers had taken Paxil early in pregnancy was about 2 percent, compared with a 1 percent risk in the general population.
The new type of array is called microECoG because it is small or micro versions of the electrodes used for electrocorticography more or ECOG, has developed half a century.